Licensing Out

Licensing Out activity

Licensing Out is the Department of IUCT in charge of negotiating the license of products & technologies obtained as a result of its research activity.

From the projects that are carried out in InKemia IUCT group we obtain new products, processes and technologies that become part of the group’s pipeline and can be patented, used as know-how or become part of a new technological platform. All these new technologies could later become part of the industry through a technological transfer process or a license.

Exopolysaccharides

InKemia IUCT has found a wide variety of exopolysaccharides (EPS), products with a high potential as active ingredients in several fields like human and veterinary drugs, cosmetics, and functional foods among others. We have about 100 different compounds up to date, the majority of them ready to be tested. Through different co-development agreements InKemia IUCT has started several research lines to study the use of our EPS in Alzheimer’s disease and cosmetic applications and we will start new researches soon to increase the use of the EPS.

Drug Discovery libraries

We have a variable number of compounds already synthetized for their use in the research of new drugs

Biofuels Advanced

To get more information about these EPS click here.

INKEMIA IUCT GROUP’S PATENTS

InKemia’s IUCT group knowledge division now reaches the number of 62 patents granted.

These granted patents are of international nature and reach over 20 different countries, some of these patents have long term potential and can be exploited until the year 2030.

It is important to note that a great number of these patents are currently under revision and their gradual approval is expected over the next few months. Both the patents in process and the granted ones can be concentrated into 25 groups that are multiplied as they are presented throughout different countries, therefore all the patents could result in over 150 patents by the end of the process.

The 62 granted patents are grouped into three important areas of development

• Drug Discovery-Biomedicine
• Industrial biotechnology and Biofuels
• Green Chemistry and “Green products”

Pharmaceutical development-Drug Discovery-Biomedicine

Libraries of small molecules with potential for anti-inflammatory activity “N-(1-Fenil-2-oxo-3-piperidil) sulfonamides for the identification of biological and pharmaceutical activity”

Libraries of small molecules with potential for anti-inflammatory activity “N-Fenil-1-sulfonil-2-pirrolidinacarboxamidas for the identification of biological and pharmaceutical activity”

New biocatalysts for the obtention of pharmaceutical active principles anticarcinogenic and antivirus “Thermostable biocatalyst combination for nucleoside synthesis”

Industrial Biotechnology and Carburants

New second generation biofuel. “Obtention of fatty acid esters from glycerol formal and used as biofuel”

Synthesis of pharmaceutical intermediaries by means of green chemistry. “Procedure of Friedel-Crafts reaction in ionic liquids”

Biosynthesis of K3 vitamin. “Microbiological procedure for the preparation of menadione”

Green Chemistry y Green Products

New green solvents for degreasing metals. “Compositions for degreasing hard surfaces”

Synthesis of pharmaceutical active principles by means of green chemistry. “Process for the preparation of LOPERAMIDE”

Synthesis of pharmaceutical active principles by means of green chemistry. “Process for the preparation of the PIMOZIDE”